VEGF165 antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

349

HTML

2460

Figures (1-4)

201

Sum=3010

Feb 15, 2002 (publication date) through Sep 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Esophageal Cancer

World J Gastroenterol. Feb 15, 2002; 8(1): 44-48
Published online Feb 15, 2002. doi: 10.3748/wjg.v8.i1.44

Full Size Figure Download Figure

Figure 4 Expression of VEGF₁₆₅ in Ec109 cell ( × 40): transfected by pCEP-AVEGF₁₆₅ (A), transfected by empty vector (B), and control group (C).

Citation: Gu ZP, Wang YJ, Li JG, Zhou YA. VEGF₁₆₅ antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma. World J Gastroenterol 2002; 8(1): 44-48
URL: https://www.wjgnet.com/1007-9327/full/v8/i1/44.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i1.44